Jump to content
TedderVision
Sign in to follow this  
TexAgRepublican

Bipartisan Healthcare Act

Recommended Posts

Ms. Van Horn and Mr. Doyle in the House, Mr. Conway and Mr. O'Rourke in the Senate, on behalf of President Fitzgerald, with thanks to Mr. Biggs submits

A BILL

To replace the Affordable Care Act.

SEC. 1. SHORT TITLE.

(a) This act shall be cited as the Bipartisan Healthcare Act. 

SEC. 2. AMENDMENT TO AMERICA FIRST HEALTHCARE ACT.

(a) Section 2 of the America First Healthcare Act shall be amended to read as follows:

"(a) Patient Protection And Affordable Care Act.—Effective on January 1, 2021 2025 the Patient Protection and Affordable Care Act (Public Law 111–148) is repealed and the provisions of law amended or repealed by such Act are restored or revived as if such Act had not been enacted.

(b) Health Care And Education Reconciliation Act Of 2010.—Effective on January 1, 2021 2025 the Health Care and Education Reconciliation Act of 2010 (Public Law 111–152) is repealed and the provisions of law amended or repealed by such Act are restored or revived as if such Act had not been enacted."

SEC. 3. HEALTHCARE BLOCK GRANTS FOR STATES.

(a) $200,000,000,000 will be appropriated annually beginning in FY2025 to each State government in the form of a block grant, with the total appropriation being divided on a per capita basis according to the total population of each State.

(b) The money must be used for the purposes of providing affordable and accessible healthcare to the citizens of each state. 

SEC. 4. REMOVAL OF INTERSTATE HEALTH INSURANCE BARRIERS.

(a) No federal law shall be enforced for the purpose of restricting or prohibiting the interstate sale of health insurance.

SEC. 5. PRE-EXISTING CONDITIONS.

(a) No public or private insurance provider is authorized to deny coverage or require additional charge to a beneficiary on the basis of pre-existing conditions or age.

SEC. 6. YOUNG ADULT COVERAGE.

(a) Adult children can remain on their parents' or legal guardian's insurance until they are 26 years old.

SEC. 7. RIGHT TO TRY.

(a) The federal government is required to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are: (1) intended to treat a patient who has been diagnosed with a terminal illness, and (2) authorized by state law. The federal government must allow unrestricted possession and use of such treatments by patients certified by a physician as having exhausted all other treatment options.

(b) A manufacturer, distributor, prescriber, dispenser, possessor, or user of such a treatment has no liability regarding the treatment.

(c) The outcome of manufacture, distribution, prescribing, dispensing, possession, or use of such a treatment may not be used by a federal agency to adversely impact review or approval of the treatment.

(d) The treatment must: (1) have successfully completed a phase 1 (initial, small scale) clinical trial; (2) remain under investigation in a clinical trial approved by the Food and Drug Administration; and (3) not be approved, licensed, or cleared for sale under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act.

SEC. 8. ENACTMENT.

(a) Unless otherwise stated, this act shall take effect immediately. 

Share this post


Link to post
Share on other sites
On 5/22/2018 at 3:54 PM, TexAgRepublican said:

Ms. Van Horn and Mr. Doyle in the House, Mr. Conway and Mr. O'Rourke in the Senate, on behalf of President Fitzgerald, with thanks to Mr. Biggs submits

A BILL

To replace the Affordable Care Act.

SEC. 1. SHORT TITLE.

(a) This act shall be cited as the Bipartisan Healthcare Act. 

SEC. 2. AMENDMENT TO AMERICA FIRST HEALTHCARE ACT.

(a) Section 2 of the America First Healthcare Act shall be amended to read as follows:

"(a) Patient Protection And Affordable Care Act.—Effective on January 1, 2021 2025 the Patient Protection and Affordable Care Act (Public Law 111–148) is repealed and the provisions of law amended or repealed by such Act are restored or revived as if such Act had not been enacted.

(b) Health Care And Education Reconciliation Act Of 2010.—Effective on January 1, 2021 2025 the Health Care and Education Reconciliation Act of 2010 (Public Law 111–152) is repealed and the provisions of law amended or repealed by such Act are restored or revived as if such Act had not been enacted."

SEC. 3. HEALTHCARE BLOCK GRANTS FOR STATES.

(a) $200,000,000,000 will be appropriated annually beginning in FY2025 to each State government in the form of a block grant, with the total appropriation being divided on a per capita basis according to the total population of each State.

(b) The money must be used for the purposes of providing affordable and accessible healthcare to the citizens of each state. 

SEC. 4. REMOVAL OF INTERSTATE HEALTH INSURANCE BARRIERS.

(a) No federal law shall be enforced for the purpose of restricting or prohibiting the interstate sale of health insurance.

SEC. 5. PRE-EXISTING CONDITIONS.

(a) No public or private insurance provider is authorized to deny coverage or require additional charge to a beneficiary on the basis of pre-existing conditions or age.

SEC. 6. YOUNG ADULT COVERAGE.

(a) Adult children can remain on their parents' or legal guardian's insurance until they are 26 years old.

SEC. 7. RIGHT TO TRY.

(a) The federal government is required to allow unrestricted manufacturing, distribution, prescribing, and dispensing of experimental drugs, biological products, and medical devices that are: (1) intended to treat a patient who has been diagnosed with a terminal illness, and (2) authorized by state law. The federal government must allow unrestricted possession and use of such treatments by patients certified by a physician as having exhausted all other treatment options.

(b) A manufacturer, distributor, prescriber, dispenser, possessor, or user of such a treatment has no liability regarding the treatment.

(c) The outcome of manufacture, distribution, prescribing, dispensing, possession, or use of such a treatment may not be used by a federal agency to adversely impact review or approval of the treatment.

(d) The treatment must: (1) have successfully completed a phase 1 (initial, small scale) clinical trial; (2) remain under investigation in a clinical trial approved by the Food and Drug Administration; and (3) not be approved, licensed, or cleared for sale under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act.

SEC. 8. ENACTMENT.

(a) Unless otherwise stated, this act shall take effect immediately. 

 

Van Horne
Republicans Democrats
NAT EV BUS MR ML SJW PRO EN
Change +5 +1 -10 +10 +10 +5 +5 +5

 

 

Doyle
Republicans Democrats
NAT EV BUS MR ML SJW PRO EN
Change +5 +1 -10 +10 +10 +5 +5 +5

 

Fitzgerald
Republicans Democrats
NAT EV BUS MR ML SJW PRO EN
Change +5 +1 -10 +10 +10 +5 +5 +5

 

Conway
Republicans Democrats
NAT EV BUS MR ML SJW PRO EN
Change +5 +1 -10 +10 +10 +5 +5 +5

 

O'Rourke
Republicans Democrats
NAT EV BUS MR ML SJW PRO EN
Change +5 +1 -10 +10 +10 +5 +5 +5

Share this post


Link to post
Share on other sites
Guest
This topic is now closed to further replies.
Sign in to follow this  

  • Recently Browsing   0 members

    No registered users viewing this page.

×